Get startedLog in
    Picture of Oxford Cannabinoid Technologies Holdings logo

    OCTP — Oxford Cannabinoid Technologies Holdings News Story

    0.000.00%
    gb flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Oxford Cannabinoid Technologies Says First Dose Administered In Phase I Clinical Trial For Lead Drug Candidate OCT461201

    Picture of Oxford Cannabinoid Technologies Holdings logoOxford Cannabinoid Technologies Holdings
    27/07/2023 07:57
    July 27 (Reuters) - Oxford Cannabinoid Technologies
Holdings PLC  OCTP.L :
    * OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC - FIRST DOSE
ADMINISTERED IN PHASE I CLINICAL TRIAL FOR LEAD DRUG CANDIDATE
OCT461201
    * OXFORD CANNABINOID TECHNOLOGIES HOLDINGS - RESULTS FROM
TRIAL,
WHICH IS BEING FUNDED ENTIRELY FROM OCTP'S EXISTING RESOURCES,
EXPECTED IN Q3 2023

Source text for Eikon:  ID:nRSa3123Ha 
Further company coverage:  OCTP.L 

 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on Oxford Cannabinoid Technologies Holdings

    See all news